Pacira BioSciences, Inc. SEC filings PCRX

Pacira BioSciences, Inc. has 1,002 filings in SEC EDGAR's recent list, going back to Mar 31, 2014. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 4, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 8, 2026 (material agreement, regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
S-8 Employee stock plan registration Aug 4, 2026 —
S-8 Employee stock plan registration Feb 26, 2026 —
S-8 Employee stock plan registration Aug 5, 2025 —
S-8 Employee stock plan registration Feb 27, 2025 —
S-8 Employee stock plan registration Feb 29, 2024 —
S-8 Employee stock plan registration Aug 2, 2023 —
S-8 Employee stock plan registration Aug 4, 2022 —
S-8 Employee stock plan registration Aug 3, 2021 —
S-8 Employee stock plan registration Aug 8, 2019 —
S-8 Employee stock plan registration Jun 17, 2016 —
S-8 Employee stock plan registration Jun 5, 2014 —
424B5 Prospectus supplement Apr 9, 2014 —
424B5 Prospectus supplement Apr 7, 2014 —
S-3ASR Automatic shelf registration Apr 7, 2014 —

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
PCRX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Brisbane, CA
SEC filer status
Large accelerated filer
SEC CIK
1396814
Former names
Pacira Pharmaceuticals, Inc. (until Apr 9, 2019); PACIRA INC (until Nov 5, 2008); Blue Acquisition Corp (until Apr 16, 2007)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.